A citation-based method for searching scientific literature

Tianrui Yang, Ziren Kong, Wenbin Ma. Hum Vaccin Immunother 2021
Times Cited: 3







List of co-cited articles
22 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


GSVA: gene set variation analysis for microarray and RNA-seq data.
Sonja Hänzelmann, Robert Castelo, Justin Guinney. BMC Bioinformatics 2013
100

Mechanisms and therapeutic implications of hypermutation in gliomas.
Mehdi Touat, Yvonne Y Li, Adam N Boynton, Liam F Spurr, J Bryan Iorgulescu, Craig L Bohrson, Isidro Cortes-Ciriano, Cristina Birzu, Jack E Geduldig, Kristine Pelton,[...]. Nature 2020
130
66

CGCG clinical practice guidelines for the management of adult diffuse gliomas.
Tao Jiang, Ying Mao, Wenbin Ma, Qing Mao, Yongping You, Xuejun Yang, Chuanlu Jiang, Chunsheng Kang, Xuejun Li, Ling Chen,[...]. Cancer Lett 2016
223
66



Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
Roger Stupp, Sophie Taillibert, Andrew Kanner, William Read, David Steinberg, Benoit Lhermitte, Steven Toms, Ahmed Idbaih, Manmeet S. Ahluwalia, Karen Fink,[...]. JAMA 2017
656
66

RCircos: an R package for Circos 2D track plots.
Hongen Zhang, Paul Meltzer, Sean Davis. BMC Bioinformatics 2013
190
66

Robust enumeration of cell subsets from tissue expression profiles.
Aaron M Newman, Chih Long Liu, Michael R Green, Andrew J Gentles, Weiguo Feng, Yue Xu, Chuong D Hoang, Maximilian Diehn, Ash A Alizadeh. Nat Methods 2015
66

Maftools: efficient and comprehensive analysis of somatic variants in cancer.
Anand Mayakonda, De-Chen Lin, Yassen Assenov, Christoph Plass, H Phillip Koeffler. Genome Res 2018
611
66

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Peng Jiang, Shengqing Gu, Deng Pan, Jingxin Fu, Avinash Sahu, Xihao Hu, Ziyi Li, Nicole Traugh, Xia Bu, Bo Li,[...]. Nat Med 2018
518
66

GenVisR: Genomic Visualizations in R.
Zachary L Skidmore, Alex H Wagner, Robert Lesurf, Katie M Campbell, Jason Kunisaki, Obi L Griffith, Malachi Griffith. Bioinformatics 2016
118
66

Inferring tumour purity and stromal and immune cell admixture from expression data.
Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez, Rahulsimham Vegesna, Hoon Kim, Wandaliz Torres-Garcia, Victor Treviño, Hui Shen, Peter W Laird, Douglas A Levine,[...]. Nat Commun 2013
66

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.
Craig H Mermel, Steven E Schumacher, Barbara Hill, Matthew L Meyerson, Rameen Beroukhim, Gad Getz. Genome Biol 2011
66

Classification of triple-negative breast cancers based on Immunogenomic profiling.
Yin He, Zehang Jiang, Cai Chen, Xiaosheng Wang. J Exp Clin Cancer Res 2018
109
66

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho,[...]. Science 2015
66

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Michael Weller, Nicholas Butowski, David D Tran, Lawrence D Recht, Michael Lim, Hal Hirte, Lynn Ashby, Laszlo Mechtler, Samuel A Goldlust, Fabio Iwamoto,[...]. Lancet Oncol 2017
419
66

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.
Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy Cloughesy, Olivier L Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson,[...]. J Clin Oncol 2015
180
66

Critical limitations of consensus clustering in class discovery.
Yasin Șenbabaoğlu, George Michailidis, Jun Z Li. Sci Rep 2014
82
66

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma.
Xin Wang, Gaochao Guo, Hui Guan, Yang Yu, Jie Lu, Jinming Yu. J Exp Clin Cancer Res 2019
80
66

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
David A Reardon, Alba A Brandes, Antonio Omuro, Paul Mulholland, Michael Lim, Antje Wick, Joachim Baehring, Manmeet S Ahluwalia, Patrick Roth, Oliver Bähr,[...]. JAMA Oncol 2020
207
66

A randomized trial of bevacizumab for newly diagnosed glioblastoma.
Mark R Gilbert, James J Dignam, Terri S Armstrong, Jeffrey S Wefel, Deborah T Blumenthal, Michael A Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie Pugh, Minhee Won,[...]. N Engl J Med 2014
66

Subclass mapping: identifying common subtypes in independent disease data sets.
Yujin Hoshida, Jean-Philippe Brunet, Pablo Tamayo, Todd R Golub, Jill P Mesirov. PLoS One 2007
155
66

The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells.
Seung-Hyun Jeon, Se Hyun Kim, Yeni Kim, Yong Sik Kim, Yoongho Lim, Young Han Lee, Soon Young Shin. Biochem Biophys Res Commun 2011
61
33

Cancer stem cells in glioblastoma.
Justin D Lathia, Stephen C Mack, Erin E Mulkearns-Hubert, Claudia L L Valentim, Jeremy N Rich. Genes Dev 2015
734
33

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
Eric Bouffet, Valérie Larouche, Brittany B Campbell, Daniele Merico, Richard de Borja, Melyssa Aronson, Carol Durno, Joerg Krueger, Vanja Cabric, Vijay Ramaswamy,[...]. J Clin Oncol 2016
453
33

Pathway-Based Genomics Prediction using Generalized Elastic Net.
Artem Sokolov, Daniel E Carlin, Evan O Paull, Robert Baertsch, Joshua M Stuart. PLoS Comput Biol 2016
46
33

Notch promotes radioresistance of glioma stem cells.
Jialiang Wang, Timothy P Wakeman, Justin D Lathia, Anita B Hjelmeland, Xiao-Fan Wang, Rebekah R White, Jeremy N Rich, Bruce A Sullenger. Stem Cells 2010
405
33

Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis.
Jan Yperman, Thijs Becker, Dirk Valkenborg, Veronica Popescu, Niels Hellings, Bart Van Wijmeersch, Liesbet M Peeters. BMC Neurol 2020
12
33

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.
Qijin Xu, Gentao Liu, Xiangpeng Yuan, Minlin Xu, Hongqiang Wang, Jianfei Ji, Bindu Konda, Keith L Black, John S Yu. Stem Cells 2009
142
33

Gene Expression Value Prediction Based on XGBoost Algorithm.
Wei Li, Yanbin Yin, Xiongwen Quan, Han Zhang. Front Genet 2019
29
33

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Shideng Bao, Qiulian Wu, Roger E McLendon, Yueling Hao, Qing Shi, Anita B Hjelmeland, Mark W Dewhirst, Darell D Bigner, Jeremy N Rich. Nature 2006
33


Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues.
Craig Horbinski, Julia Kofler, Lindsey M Kelly, Geoffrey H Murdoch, Marina N Nikiforova. J Neuropathol Exp Neurol 2009
118
33

Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Anna M Bielecka-Wajdman, Marta Lesiak, Tomasz Ludyga, Aleksander Sieroń, Ewa Obuchowicz. Cancer Chemother Pharmacol 2017
12
33

Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden.
Jan Budczies, Anja Seidel, Petros Christopoulos, Volker Endris, Matthias Kloor, Balázs Győrffy, Barbara Seliger, Peter Schirmacher, Albrecht Stenzinger, Carsten Denkert. Oncoimmunology 2018
32
33


TERT promoter mutations contribute to subset prognostication of lower-grade gliomas.
Aden Ka-Yin Chan, Yu Yao, Zhenyu Zhang, Nellie Yuk-Fei Chung, Joseph Shu-Ming Liu, Kay Ka-Wai Li, Zhifeng Shi, Danny Tat-Ming Chan, Wai Sang Poon, Liangfu Zhou,[...]. Mod Pathol 2015
71
33

Genetic basis for clinical response to CTLA-4 blockade in melanoma.
Alexandra Snyder, Vladimir Makarov, Taha Merghoub, Jianda Yuan, Jesse M Zaretsky, Alexis Desrichard, Logan A Walsh, Michael A Postow, Phillip Wong, Teresa S Ho,[...]. N Engl J Med 2014
33

The Immune Landscape of Cancer.
Vésteinn Thorsson, David L Gibbs, Scott D Brown, Denise Wolf, Dante S Bortone, Tai-Hsien Ou Yang, Eduard Porta-Pardo, Galen F Gao, Christopher L Plaisier, James A Eddy,[...]. Immunity 2018
33

Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.
Krishna P L Bhat, Veerakumar Balasubramaniyan, Brian Vaillant, Ravesanker Ezhilarasan, Karlijn Hummelink, Faith Hollingsworth, Khalida Wani, Lindsey Heathcock, Johanna D James, Lindsey D Goodman,[...]. Cancer Cell 2013
553
33

EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner.
Sung-Hak Kim, Kaushal Joshi, Ravesanker Ezhilarasan, Toshia R Myers, Jason Siu, Chunyu Gu, Mariko Nakano-Okuno, David Taylor, Mutsuko Minata, Erik P Sulman,[...]. Stem Cell Reports 2015
107
33

Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma.
Ganxun Li, Weiqi Xu, Lu Zhang, Tongtong Liu, Guannan Jin, Jia Song, Jingjing Wu, Yuwei Wang, Weixun Chen, Chuanhan Zhang,[...]. EBioMedicine 2019
21
33

Glioblastoma stem cells and stem cell-targeting immunotherapies.
Rogelio Esparza, Tej D Azad, Abdullah H Feroze, Siddhartha S Mitra, Samuel H Cheshier. J Neurooncol 2015
17
33

Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells.
Stacey Watkins, Stefanie Robel, Ian F Kimbrough, Stephanie M Robert, Graham Ellis-Davies, Harald Sontheimer. Nat Commun 2014
254
33

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly.
Guido Reifenberger, Bettina Hentschel, Jörg Felsberg, Gabriele Schackert, Matthias Simon, Oliver Schnell, Manfred Westphal, Wolfgang Wick, Torsten Pietsch, Markus Loeffler,[...]. Int J Cancer 2012
175
33

Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.
Serena Pellegatta, Pietro Luigi Poliani, Daniela Corno, Francesca Menghi, Francesco Ghielmetti, Blanca Suarez-Merino, Valentina Caldera, Sara Nava, Maria Ravanini, Fabio Facchetti,[...]. Cancer Res 2006
193
33

Amitriptyline down-regulates coenzyme Q10 biosynthesis in lung cancer cells.
Tamara Ortiz, Marina Villanueva-Paz, Eduardo Díaz-Parrado, Matilde Illanes, Ana Fernández-Rodríguez, José A Sánchez-Alcázar, Manuel de Miguel. Eur J Pharmacol 2017
1
100

Temozolomide for immunomodulation in the treatment of glioblastoma.
Aida Karachi, Farhad Dastmalchi, Duane A Mitchell, Maryam Rahman. Neuro Oncol 2018
60
33

KEGG: new perspectives on genomes, pathways, diseases and drugs.
Minoru Kanehisa, Miho Furumichi, Mao Tanabe, Yoko Sato, Kanae Morishima. Nucleic Acids Res 2017
33

Structural and functional features of central nervous system lymphatic vessels.
Antoine Louveau, Igor Smirnov, Timothy J Keyes, Jacob D Eccles, Sherin J Rouhani, J David Peske, Noel C Derecki, David Castle, James W Mandell, Kevin S Lee,[...]. Nature 2015
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.